Analysts/Institutional Investor Meet/Con. Call Updates

Ref: OAL/BSE/NSE/31/2026-27 04th August, 2026 To To The Manager The Manager Department of Corporate Services, Listing Department, BSE Limited, National Stock Exchange of India Limited Phiroz Jeejeebhoy Towers Exchange Plaza, Bandra Kurla Complex Dalal Street, Mumbai- 400 001 B a n d r a ( E a s t ) , Mumbai - 400 051 Scrip ID : OAL Symbol: OAL Scrip Code: 500078 Series : EQ Sub: Transcript of conference call with the Institutional Investors/Analysts With reference to our letter dated 27th July, 2026, intimating about the conference call with the Institutional Investors/Analysts on Friday, 31st July, 2026 at 02:30 p.m. to discuss the financial performance of the Company for the quarter ended 30th June, 2026, please find attached herewith transcript of the aforesaid conference call. Further, the copy of the same is also uploaded on Company’s website i.e. www.orientalaromatics.com. Kindly take the information on your record. Thanking you, Yours Faithfully For Oriental Aromatics Limited Dharmil A. Bodani Chairman & Managing Director DIN: 00618333 Registered Office 133, Jehangir Building, 2nd Floor, M.G. Road, Fort, Mumbai 400 001, India. T +91-22-66556000 / 43214000 F +91-22-66556099 E oa@orientalaromatics.com CIN L17299MH1972PLC285731 www.orientalaromatics.com Oriental Aromatics Limited Q1 FY’27 Earnings Conference Call July 31, 2026 Moderator: Ladies and gentlemen, good day and welcome to Oriental Aromatics Limited Q1FY27 Earnings Conference Call. As a reminder, all participant lines will be in the listen-only mode and there will be an opportunity for you to ask questions after the presentation concludes. Should you need assistance during the conference call, please signal an operator by pressing “*” and then “0” on your touchtone phone. Please note that this conference is being recorded. I now hand the conference over to Ms. Purvangi Jain from Valorem Advisors. Thank you and over to you ma'am. Purvangi Jain: Thank you. Good afternoon, everyone and a very warm welcome to you all. My name is Purvangi Jain from Valorem Advisors. We represent the investor relations of Oriental Aromatics Limited. On behalf of the company, I would like to thank you all for participating in the company's earnings conference call for the 1st Quarter of the Financial Year 2027. Before we begin, let me mention a short cautionary statement. Some of the statements made in today's Earnings Call may be forward-looking in nature. Such forward-looking statements are subject to risks and uncertainties which could cause actual results to differ from those anticipated. Such statements are based on management's belief as well as assumptions made by and information currently available to the management. Audiences are cautioned not to place any undue reliance on these forward-looking statements in making any investment decision. The purpose of today's earnings call is purely to educate and bring awareness about the company's fundamental business and financial quarter under review. Now let me introduce you to the management participating with us in today's earnings call and hand it over to them for their opening remarks. We have with us Mr. Dharmil Bodani – Chairman and Managing Director, Mr. Shyamal Bodani – Executive Director, Mr. Parag Satoskar – Chief Executive Officer, Mr. Girish Khandelwal – Chief Financial Officer, and Ms. Kiranpreet Gill– Company Secretary and Compliance Officer. Without any further delay, I request Mr. Dharmil Bodani to start with his opening remarks. Thank you and over to you, sir. Page 1 of 14 Dharmil Bodani: Thank you, Purvangi. Good afternoon, everybody. It is a pleasure to welcome you all to the Quarterly Earnings Call of Oriental Aromatics Limited. Quarter 1 represents a positive start to the financial year for the company. Our performance during the quarter reflects healthy year-on-year growth in revenue and volumes, improved operating efficiencies and a sequential recovery in profitability. While the external environment continues to remain challenging and input costs remain elevated, the direction of our performance is encouraging. Our diversified presence across Flavors, Fragrances, Specialty Aroma Ingredients and Camphor and Terpene Chemicals continues to provide resilience across market cycles. Our Executive Director – Mr. Shyamal Bodani will now take you through the Operational Performance and Key Developments during this quarter. Thereafter, our CFO – Mr. Girish Khandelwal will brief you on the Financial Highlights. Over to you, Shyamal. Thank you. Shyamal Bodani: Thank you, Dharmil. Good afternoon, everyone. Q1 FY27 has been an encouraging start to the financial year with healthy year-on-year growth in revenue, productions and sales volume accompanied by sequential improvement in operating margins. Our consolidated revenue from operations for the quarter stood at approximately Rs. 260 crores, compared with approximately Rs. 226 crores in the corresponding quarter last year, representing growth of around 15% year-on-year. More importantly, this growth was supported by a strong increase in physical volumes, total sales volume increased by 22% year-on-year, while production volumes grew by 18% year-on- year, reflecting healthy manufacturing utilization, improved operational execution and sustained demand across our key products categories. On a sequential basis, product volumes remained broadly stable. This was primarily attributed to the changes in product mix and the normal quarterly seasonal movement across our three businesses. Our EBITDA margins for the quarter stood at 7.62%, representing an improvement of 71 basis points, sequentially from 6.89% in Q4 FY26. This improvement was supported by a favorable product mix, improved sales realizations, and the benefit of operational efficiency programs undertaken across our manufacturing locations. While EBITDA margins were marginally lower than the corresponding quarter last year, primarily due to higher raw material costs, we believe the sequential improvement reflects the direction in which the business is progressing. Page 2 of 14 Now let me take you through the performances of our three businesses: Fragrance and Flavors Division continues to deliver a resilient performance during the quarter. Demand across our key customer categories remained healthy and we continued to deepen our relationships with existing customers while progressing new business opportunities across both domestic and international markets. Production and sales volumes at Ambarnath were marginally lower year-on-year during the quarter. The primary reason for this was the seasonal nature of business and should not be viewed as a change in the underlying direction of the division. Our brief pipeline remains healthy and we continue to focus on expanding customer relationships, increasing wallet share and converting development projects into sustainable commercial businesses. Our Speciality Aroma Ingredients business delivered healthy year-on-year growth in both productions and sales volume during the quarter. However, the broader global market for ingredients continues to remain highly competitive. Capacity additions, particularly across Asia, continue to exert pressure on selling prices for several products. The industry remains a buyer's market across many ingredients categories with customers continuing to expect competitive pricing together with high quality, innovation and security of supply. At the same time, several natural and petrochemical-derived raw materials continue to remain elevated, creating an environment where input costs remain firm while finished product pricing continues to be competitive. Our response continues to be disciplined and structural. We continue to focus on process re- engineering, yield improvement, energy optimization, internalization of intermediaries, and greater utilization of our multi-chemistry manufacturing platforms. These initiatives are intended to improve our cost position independent [Showing first 8,000 characters — download PDF for full document]